Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor α1 and α2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme-Reference-Cited by-同舟云学术

Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor α1 and α2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme

Published:2017-11-22 Issue:3 Volume:136 Page:463-474
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Han Jing^ORCID,Puri Raj K.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Neurology,Oncology

Link

http://link.springer.com/article/10.1007/s11060-017-2680-9/fulltext.html

Reference46 articles.

1. Bastien JIL, McNeill KA, Fine HA (2015) Molecular characterizations of glioblastoma, targeted therapy, and clinical results to date. Cancer 121(4):502–516

2. Natsume A, Kinjo S, Yuki K, Kato T, Ohno M et al (2011) glioma initiating cells and molecular pathology: implications for therapy. Brain Tumor Pathol 28:1–12

3. Phillips HS, Samir Kharbanda S, Chen R, Forrest WF, Robert H, Soriano RH et al (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9:157–173

4. Verhaak RGW, Hoadley KA, Purdom E, Wang V, Qi Y et al (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17:98–110

5. Kim YW, Koul D, Kim SH, Lucio-Eterovic AK, Freire PR, Yao J et al (2013) Identification of prognostic gene signatures of glioblastoma: a study based on TCGA data analysis. Neuro Oncol 15(7):829–839. https://doi.org/10.1093/neuonc/not024

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Suppressive immune microenvironment and CART therapy for glioblastoma: Future prospects and challenges;Cancer Letters;2024-09

2. mRNA markers for survival prediction in glioblastoma multiforme patients: a systematic review with bioinformatic analyses;BMC Cancer;2024-05-21

3. Identification and characterisation of novel CAR‐T cells to target IL13Rα2 positive human glioma in vitro and in vivo;Clinical and Translational Medicine;2024-04-29

4. Predictive Model to Identify the Long Time Survivor in Patients with Glioblastoma: A Cohort Study Integrating Machine Learning Algorithms;Journal of Molecular Neuroscience;2024-04-25

5. The MexTAg collaborative cross: host genetics affects asbestos related disease latency, but has little influence once tumours develop;Frontiers in Toxicology;2024-04-17